Cystistat® is used for the temporary replacement of the glycosaminoglycan (GAG) layer in the bladder, for the symptomatic treatment of bladder conditions such as interstitial cystitis (IC).1 It may also be used to treat cystitis caused by infections, trauma, urolithiasis, urinary retention, neoplasia or radiation.
Cystistat® (sodium hyaluronate) is approved as a Class III medical device.
Each Cystistat® vial contains: 40mg sodium hyaluronate.
Cystistat® is instilled in a routine procedure directly into the bladder.1
CE 0344 Device
1 Cystistat® (sodium hyaluronate) Instructions For Use.
To access this section of the Teva UK Limited website you need to be a member of the healthcare profession
because the materials included in this area of our website are specifically prepared for that audience
To understand why that is - please visit: Working in a regulated environment
Please click on the appropriate button below to confirm that you are healthcare professional.
If you are not a healthcare professional, you will be taken to an area of the website that is appropriate for you.